John Fairbanks
Analyst · Craig-Hallum. Your line is open
Thanks Don. I’d like to start by running through our reported financial results for the second quarter and the first six months of 2018 at a summary level. Second quarter total revenue declined 14% to $21.7 million versus $25.1 million in 2017. Second quarter net loss was $7 million or $0.29 per share versus a net loss of $5.5 million or $0.23 per share last year. Second quarter adjusted EBITDA was negative $3.2 million compared to negative $1.4 million a year ago. We define adjusted EBITDA as net income or loss for interest, taxes, depreciation, amortization, stock-based compensation expense and any other items that we do not believe are indicative of our core operating performance. We incurred $146,000 of patent enforcement costs during the second quarter of 2018 versus $152,000 in the second quarter last year. For the first half, total revenue declined 7%, $44.7 million. Net loss was $13.8 million or $0.58 per share in the first half of 2018 versus a net loss of $14.6 million or $0.62 per share last year, and adjusted EBITDA for the first half of 2018 was negative $5.6 million compared to negative $6.6 million last year. We incurred $235,000 of patent enforcement costs in the first half of 2018 versus $2.9 million during the first half of 2017. I will now provide additional detail on the components of our first half results. First, I’ll discuss revenue. First half total revenue was comprised of product revenue of $43.6 million and research services revenue of $1.1 million. During the first half, product revenue decreased by $3.3 million or 7% versus last year's $46.9 million. This decrease was driven by the successful conclusion during 2017 of the multi-year South Asia petrochemical project and several key LNG projects in combination with a decline in project work in the subsea market during the first half of 2018. The decline in project related revenue was partially offset by solid first half growth in our core petrochemical and refinery markets most notably in North America. During the first half of 2018, shipments decreased 12% to 14. 9 million square feet of aerogel blankets for our average selling price increased by 6% to $2.93 per square foot in line with our prior outlook. This increase in average selling price reflected the impact of price increases enacted in early 2018 and year-over-year improvement in the mix of products sold. I’ll now turn to our research services revenue. Our research services revenue is related to contract research performed principally for government agencies. Research services revenue decreased by 6% during the first half of 2018, a $1.1 million from $1.2 million during the first half of 2017. This decline was due to the relative value and timing of research contracts versus last year. For the full year we continue to project research services revenue of approximately $1.75 million down slightly from 2017. This expectation is included in our 2018 guidance. At the time of our first quarter earnings call in May, we anticipated that broad based growth across our core and adjacent markets in 2018 would offset most or all of the expected decline in product revenue both in the subsea market and associated with the completion of the South Asia petrochemical project. Although we experienced growth in our core petrochemical and refinery markets during the first half of the year, the decline in our adjacent markets due to the completion of key LNG projects will make this objective difficult to achieve. As a result, we have reduced the range of our 2018 product revenue guidance between $100 million and $110 million, a decrease of $4 million from prior guidance. This reduction is principally the result of the decrease in projected shipment volumes. We continue to expect that the average selling price of our aerogel blankets for the full-year remain flat with 2017 at $2.92 per square foot plus or minus $0.05. Next, I'll discuss gross profit. Gross profit was $5.6 million, a 12% of revenue during the first half of 2018 versus $5.9 million or 12% last year. This decrease in first half gross profit was driven by 7% decline in product revenue, and a increase in the cost of silica materials as constitute over half of the raw material costs of our aerogel blanket. Offset in part by the impacts of our 2018 price increases, a decrease in warranty expense, modest cost increases in other raw materials, and solid manufacturing yields and productivity. Looking forward to the second half of 2018, we anticipate an improvement in gross profit and gross margin particularly in the fourth quarter and first half levels to the projected increases in revenue, output and capacity utilization. We also expect gross margins for the full year to reach from the low to the mid-teens. Next we’ll discuss operating expenses. For the first half of 2018, operating expenses decreased by $1.2 million or 6% to $19.2 million. This decrease in operating expenses was a result of the $2.6 million reduction of patent enforcement costs offset in part by $700,000 increase for the sales personnel and programs and a $700,000 year-over-year increase in all other operating expenses. This growth in sales and other operating expenses was driven by increases in personnel and expense to drive growth in our energy infrastructure business and to develop breakout opportunities in new markets. We're reducing our 2018 full year operating expense guidance from $39 million down to a range of between $35.9 million at the low end of our revenue guidance range and $38.6 million at the high end of our revenue guidance range. Next, I'll discuss our balance sheet and cash flow. Cash used in operations was $6.2 million during the first half of 2018 reflected our adjusted EBITDA of negative $5.6 million and an investment in working capital of $600,000 principally due to an increase in inventory levels during the period. Capital expenditures during the first half included investments in our EP20 initiative and totaled $1.7 million down from $4.8 million during the first half of 2017. During the first half of 2018, we also received prepayment from BASF at an aggregate of $5 million. We ended the first half of 2018 with $7.3 million of cash, $3.8 million on our revolving credit facility, net current assets of $23 million and shareholder's equity of the $88.9 million. In addition, we had access to an additional $8.7 million available under our revolving credit facility at the end of the first half of 2018. We’re updating our full year financial outlook for 2018 today. Total revenue is expected to range between $102 million and $112 million revised from prior guidance of $106 million to $116 million. Net loss is expected to range between $20.6 million and $22.6 million revised from prior guidance of $17.6 million to $20.6 million. Adjusted EBITDA is expected to range between a loss of $5 million and a loss of $7 million revised from a prior guidance of a loss of $2 million to $5 million. EPS is expected to range between a loss of $0.87, a loss $0.95 per share revised from prior guidance a loss of $0.74 to loss of $0.87 per share. This EPS guidance assumes a weighted average of 23.7 million shares outstanding for the year. This 2018 outlook also assumes depreciation and amortization of $10.8 million, stock-based compensation of $4.3 million and interest expense of $500,000. In addition, this financial outlook includes $1 million of costs and expenses associated with our patent enforcement actions for the full year. And as noted earlier, we expect the gross margin in the low to mid teens and an average selling price of $2.92 per square foot plus or minus $0.05 for the full year. Turning to cash in an aggregate level within the context of the adjusted EBITDA range set out in our 2018 full year outlook, we expect to exit 2018 with between $7.3 million and $10.5 million of cash on hand, the balance of $3.8 million on our revolving credit facility. We also continue to project that capital expenditures including funds dedicated to our EP20 initiative for total of $4 million for the year. I’ll now turn the call back to Jessie for Q&A.